Breast Lesion Localization Methods Market size is expected
to witness a considerable growth from 2017 to 2024: Global
Market Insights Inc.
Rising number of breast cancer surgeries and increasing awareness about disease
screening are the primary factors stimulating Breast Lesion Localization Methods
Market growth. The increasing healthcare awareness has triggered the growth of cancer
screening with respect to the related symptoms to procure timely treatment and
increase chance of survival.
The increasing demand for quality care and favorable reimbursement policies such as
Medicaid and Medicare in the U.S. will foster industry growth. Various organizations
such as the National Breast Cancer Foundation work to create awareness about disease
and promote health. Certain risks associated with the use of devices and stringent
regulatory guidelines imposed pre-marketing of the product may hinder the breast
lesion localization methods market growth.
Based on method, the breast lesion localization methods market is categorized into wire
guided localization, magnetic tracers, radioisotope localization and electromagnetic
reflectors. The wire guided segment is expected to dominate during the forecast period
owing to its constant adoption among end users. The radio-isotope method reduces the
surgery and localization time and hence is being adopted widely. This trend in adoption
of radioisotope will fuel rapid growth of radioisotope localization market size.
Based on end user, the industry is categorized into diagnostic centers, hospitals,
ambulatory surgical centers, and oncology centers. The hospital segment will
principally drive the industry during the forecast period due to increasing number of
hospitals and availability of latest technology with trained professionals.
North America breast lesion localization methods market will witness a high growth
during the forecast period owing to high prevalence of cancer, well-established
healthcare infrastructure and growing awareness about disease screening. As per the
American Cancer Society estimates, 40,610 women will die in 2017 due of breast cancer
in the U.S. This depicts the large patient pool in the region.
Europe account for second largest regional revenue share during the forecast period.
Increasing healthcare expenditure has boosted the demand for breast lesion localization
services. Various initiatives taken by European Commission to provide guidelines for
screening and diagnosis of disease will support industry growth.
1 | Page